Introduction: Arterial hypertension is frequently encountered in patients with chronic renal failure. Whether primary or secondary to kidney disease, hypertension remains an important risk factor not only for the progression of kidney disease but also for the occurrence of cardiovascular events. Currently, there is no data on the control of hypertension in CKD patients in Chad. The main objective of this study was to determine the factors of poor control of hypertension during CKD and their therapeutic modalities. Methodology: This is a cross-sectional, descriptive and analytical study carried out over a period of 8 months from September 1, 2021 to May 31, 2022 in the Nephrology Department of the Renaissance University Hospital Center in N’Djamena, Chad. During the study period, patients aged 18 years and above, which were hospitalized and/or followed for CKD with uncontrolled hypertension were included. Results: A total of 1013 patients were consulted during the study period, however, 36 cases were included, with a hospital prevalence of 3.5%. The mean age of the patients was 60 ± 9.68 years [22 and 75 years]. The patient’s history was dominated by hypertension (94.4%) and diabetes (41.7%). The main risk factors of hypertension found were diabetes (38.9%), physical inactivity (19.4%) and obesity (36.1%). Type 2 diabetes was pre-sent in 38.9% (n = 14) of the patients. There was a statistical relationship between unbalanced diabetes and poor blood pressure control (p < 0.001). Grade 1, 2 and 3 hypertension accounted for 47.2% (n = 17), 25% (n = 9) and 27.8% (n = 10), respectively. According to the GFR estimate, 12 patients (33.3%) had stage 3 chronic kidney disease, 13 patients (36.1%) had stage 4 chronic kidney disease and 11 patients (30.6%) had stage 5 chronic kidney disease. 18 patients (50%) were treated with monotherapy, 15 patients (41.7%) were treated with dual therapy with at least one included an angiotensin II receptor blocker, at least one molecule was a blocker of the renin-angiotensin system and 3 patients (8.3%) were treated using a triple antihypertensive therapy. The factors involved with poor control of hypertension were the grade of hypertension (p = 0.036), monotherapy (p = 0.042), stages 4 and 5 of CKD (p = 0.011) and dilation of the heart chambers (p < 0.001). Conclusion: Patients with chronic renal failure are at a risk of developing hypertension. Good control of blood pressure prevents deterioration of kidney function.
KeywordsHypertensionChronic Kidney DiseaseChad
Coresh, J., et al. (2007) Prevalence of Chronic Kidney Disease in the United States. JAMA, 298, 2038-2047. https://doi.org/10.1001/jama.298.17.2038
Fondation du Rein (2015). Dossier de presse de La Journée Mondiale du Rein. Journée Mondia le du Rein. http://www.fondation-du-rein.org/wp-content/uploads/2019/11/Dossier-de-Presse-Internet-2015_1.pdf
Abdoul, K. (2017) Hypertension artérielle en Afrique Subsaharienne: Les défis. 37ème journée de l’hypertension artérielle du diagnostic aux complications. 11th International Meeting of the French Society of Hypertension, Paris Cité Universitaire (CIUP), Paris, December 2017.
London, G., Marchais, S., Guérin, A. and Métivier, F. (2007) Hypertension artérielle, insuffisance rénale chronique et dialyse. Néphrologie & Thérapeutique, 3, S156-S161. https://doi.org/10.1016/S1769-7255(07)80631-6
OMS (2017) Activités de l’OMS dans la région Africaine 2016-2017: Rapport biennal de la directrice régionale. Activités de l’OMS dans la région Africaine. https://apps.who.int/iris/handle/10665/260407
Levey, A.S., Eckardt, K.-U., Dorman, N.M., et al. (2020) Nomenclature for Kidney Function and Disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference. Kidney International, 97, 1117-1129. https://doi.org/10.1016/j.kint.2020.02.010
Moumen, A., Bouziane, A., Meftah, A., Errahali, Y., Eljadi, H., Elmoussaoui, S. and Belmejdoub, G. (2016) Insuffisance rénale chronique et athérosclérose carotidienne chez le patient diabétique. La Presse Médicale, 45, e341-e349. https://doi.org/10.1016/j.lpm.2016.02.028
Stergiou, G.S., Palatini, P., Parati, G., O’Brien, E., Januszewicz, A., et al. (2021) 2021 European Society of Hypertension Practice Guidelines for Office and Out-of-Office Blood Pressure Measurement. Journal of Hypertension, 39, 1293-1302. https://doi.org/10.1097/HJH.0000000000002843
Centers for Disease Control and Prevention (CDC) (2007) Prevalence of Chronic Kidney Disease and Associated Risk Factors—United States, 1999-2004. Morbidity and Mortality Weekly Report, 56, 161-165.
Ranivoharisoa, é.M., Randriamahazo, T.R., Raherinandrasana, A.H., Ramilitiana, B., Salohimanana, R.A., Rabarijaona, M., Andriamifidison, R., Cormerais, C., Godin, F., Rakotonirina, J., Can, N.L., Quillard, M., Randriamarotia, F.W.H. and Massy, Z.A. (2022) Prévalence de la maladie rénale chronique à Antananarivo, Madagascar. Néphrologie & Thérapeutique, 18, 29-34. https://doi.org/10.1016/j.nephro.2021.08.009
Hamat, I., Mahamat Abderraman, G., Moussa Tondi, Z.M., Youssouf, M., Cisse, M.M., Tara, F., Ka, E.F., Niang, A. and Diouf, B. (2016) Epidemiological Profile of Chronic Kidney Disease at the General Hospital of National Reference of N’Djamena (Chad). Open Journal of Nephrology, 6, 78-85. https://doi.org/10.4236/ojneph.2016.63010
Appel, L.J., et al. (2010) Intensive Blood-Pressure Control in Hypertensive Chronic Kidney Disease. New England Journal of Medicine, 363, 918-929. https://doi.org/10.1056/NEJMc1011419
Mancia, G., Fagard, R., Narkiewicz, K., et al. (2013) 2013 ESH/ESC Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Blood Press, 22, 193-278. https://doi.org/10.3109/08037051.2013.812549
Chobanian, A.V., et al. (2003) Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension, 42, 1206-1252. https://doi.org/10.1161/01.HYP.0000107251.49515.c2
Nichols, W.W. and O’Rourke, M. (1998) Contours of Pressure and Flow Waves in Arteries. In: McDonald’s Blood Flow in Arteries: Theoritical, Experimental and Clinical Principles, Oxford University Press, London, 170-200.
Levey, A.S., Coresh, J., Bolton, K., et al. (2002) K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification. American Journal of Kidney Diseases, 39, S1-S266.
Vidal-Petiot, E., Metzger, M., Boffa, J.J., Haymann, J.P., Thervet, E., Houillier, P., et al. (2016) Déterminants de l’hypertension artérielle au cours de la maladie rénale chronique: Résultats de la cohorte Nephrotest. Néphrologie & Thérapeutique, 12, 378-379. https://doi.org/10.1016/j.nephro.2016.07.253
Ngoie, S.M., Mulenga, P., et al. (2017) Maladie rénale chronique: facteurs associés, étiologies, caractéristiques clinique et biologique à Lubumbashi en République Démocratique du Congo. Pan African Medical Journal, 28, Article 41. https://doi.org/10.11604/pamj.2017.28.41.9810
Bodian, M., Thiaw, A., Sarr, S.A., et al. (2017) Syndrome cardio-rénal: Aspects épidémiologiques, à propos de 36 cas dans un service de cardiologie de Dakar. Pan African Medical Journal, 28, Article 58. https://doi.org/10.11604/pamj.2017.28.58.10257
Moumen, A., et al. (2016) Insuffisance rénale chronique et athérosclérose carotidienne chez le patient diabétique. La Presse Médicale, 45, e341-e349. https://doi.org/10.1016/j.lpm.2016.02.028
Menta, I., Ba, H.O., Diall, I.B., et al. (2013) L’insuffisance renale chronique au stade infraclinique chez l’hypertendu dans le service de cardiologie du CHU Gabriel TOURE. Le Mali Médical, No. 4, 50-56.
Diallo, A.D., Adom, A.H, Toutou, T., Niamkey, E.K. and Beda, B.Y. (1998) Les néphropathies chroniques hypertensives en Côte d’Ivoire. Médecine d’Afrique Noire, 45.
Kaba, M.L., Baldé, M.D., Bah, A.O., Diallo, A. and Beavogui, M. (2005) Evaluation de l’atteinte rénale au cours de l’hypertension artérielle de l’adulte à Conakry. Mali Médical, No. 3.
Ouattara, B., Kra, O., Yao, Y., Kadjo, K. and Niamkey, E.K. (2011) Particularités de l’insuffisance rénale chronique chez des patients adultes noirs hospitalisés dans le service de médecine interne du CHU de Treichville. Néphrologie & Thérapeutique, 7, 531-534. https://doi.org/10.1016/j.nephro.2011.03.009
Hamat, I., Abderraman, G.M., Cissé, M.M., Youssouf, M., Djafar, M.S., et al. (2016) Profile of Diabetic Nephropathy at the National Reference General Hospital, N’Djamena (Chad). Pan African Medical Journal, 24, Article 193. https://doi.org/10.11604/pamj.2016.24.193.8415
Yao, K.H., N’guetta, R., Sanogo, S., Hue Lou, A., Sery, S.L. and Diallo, A.D. (2013) Syndrome cardio-rénal dans un service de médecine interne à Abidjan: à propos de 70 cas. Médecine d’Afrique Noire, 60, 38-44.
Kaze-Folefack, F., Nono, A., Halle, M.P. and Ashuntantang, G. (2013) Sévérité et contrôle de l’hypertension artérielle au cours de la maladie rénale chronique au Cameroun. La Revue Médicale de Madagascar, 3, 318-323.
Asmar, R. (2007) Pression artérielle. Régulation et épidémiologie. Mesures et valeurs normales. Néphrologie & Thérapeutique, 3, 163-184. https://doi.org/10.1016/j.nephro.2007.03.008
Weir, M.R. (2005) The Role of Combination Antihypertensive Therapy in the Prevention and Treatment of Chronic Kidney Disease. American Journal of Hypertension, 18, 100S-105S. https://doi.org/10.1016/j.amjhyper.2004.11.017
Schwenger, V. and Ritz, E. (1998) Audit of Antihypertensive Treatment in Patients with Renal Failure. Nephrology Dialysis Transplantation, 13, 3091-3095. https://doi.org/10.1093/ndt/13.12.3091